These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
48 related articles for article (PubMed ID: 15163554)
1. Functional characterization of genetic polymorphisms identified in the human cytochrome P450 4F12 (CYP4F12) promoter region. Cauffiez C; Klinzig F; Rat E; Tournel G; Allorge D; Chevalier D; Lovecchio T; Pottier N; Colombel JF; Lhermitte M; D'Halluin JC; Broly F; Lo-Guidice JM Biochem Pharmacol; 2004 Jun; 67(12):2231-8. PubMed ID: 15163554 [TBL] [Abstract][Full Text] [Related]
2. Human CYP4F12 genetic polymorphism: identification and functional characterization of seven variant allozymes. Cauffiez C; Klinzig F; Rat E; Tournel G; Allorge D; Chevalier D; Pottier N; Lovecchio T; Colombel JF; Lhermitte M; Lo-Guidice JM; Broly F Biochem Pharmacol; 2004 Dec; 68(12):2417-25. PubMed ID: 15548388 [TBL] [Abstract][Full Text] [Related]
3. First report of a genetic polymorphism of the cytochrome P450 3A43 (CYP3A43) gene: identification of a loss-of-function variant. Cauffiez C; Lo-Guidice JM; Chevalier D; Allorge D; Hamdan R; Lhermitte M; Lafitte JJ; Colombel JF; Libersa C; Broly F Hum Mutat; 2004 Jan; 23(1):101. PubMed ID: 14695544 [TBL] [Abstract][Full Text] [Related]
4. cDna cloning and expression of CYP4F12, a novel human cytochrome P450. Bylund J; Bylund M; Oliw EH Biochem Biophys Res Commun; 2001 Jan; 280(3):892-7. PubMed ID: 11162607 [TBL] [Abstract][Full Text] [Related]
5. Genetic polymorphisms and functional characterization of the 5'-flanking region of the human CYP2C9 gene: in vitro and in vivo studies. Shintani M; Ieiri I; Inoue K; Mamiya K; Ninomiya H; Tashiro N; Higuchi S; Otsubo K Clin Pharmacol Ther; 2001 Aug; 70(2):175-82. PubMed ID: 11503012 [TBL] [Abstract][Full Text] [Related]
6. Expression of CYP4F12 in gastrointestinal and urogenital epithelia. Stark K; Schauer L; Sahlén GE; Ronquist G; Oliw EH Basic Clin Pharmacol Toxicol; 2004 Apr; 94(4):177-83. PubMed ID: 15078342 [TBL] [Abstract][Full Text] [Related]
7. Four novel single nucleotide polymorphisms within the promoter region of p53 gene and their associations with uterine leiomyoma. Hsieh YY; Wang JP; Lin CS Mol Reprod Dev; 2007 Jul; 74(7):815-20. PubMed ID: 17186536 [TBL] [Abstract][Full Text] [Related]
8. Identification by single-strand conformational polymorphism analysis of known and new mutations of the CYP3A5 gene in a French population. Quaranta S; Chevalier D; Bourgarel-Rey V; Allorge D; Solas C; Lo-Guidice JM; Sampol-Manos E; Vacher-Coponat H; Moal V; Broly F; Lhermitte M; Lacarelle B Toxicol Lett; 2006 Jul; 164(2):177-84. PubMed ID: 16442753 [TBL] [Abstract][Full Text] [Related]
9. Development of a real-time polymerase chain reaction-based method for the measurement of relative allelic expression and identification of CYP2A13 alleles with decreased expression in human lung. Zhang X; Caggana M; Cutler TL; Ding X J Pharmacol Exp Ther; 2004 Oct; 311(1):373-81. PubMed ID: 15175424 [TBL] [Abstract][Full Text] [Related]
10. A nicotine C-oxidase gene (CYP2A6) polymorphism important for promoter activity. Pitarque M; von Richter O; Rodríguez-Antona C; Wang J; Oscarson M; Ingelman-Sundberg M Hum Mutat; 2004 Mar; 23(3):258-66. PubMed ID: 14974084 [TBL] [Abstract][Full Text] [Related]
11. Alport syndrome. Molecular genetic aspects. Hertz JM Dan Med Bull; 2009 Aug; 56(3):105-52. PubMed ID: 19728970 [TBL] [Abstract][Full Text] [Related]
12. Structural characterisation of the distal 5' flanking region of the human interleukin-10 gene. Kube D; Rieth H; Eskdale J; Kremsner PG; Gallagher G Genes Immun; 2001 Jun; 2(4):181-90. PubMed ID: 11477472 [TBL] [Abstract][Full Text] [Related]
13. Polymorphisms in the osteopontin promoter affect its transcriptional activity. Giacopelli F; Marciano R; Pistorio A; Catarsi P; Canini S; Karsenty G; Ravazzolo R Physiol Genomics; 2004 Dec; 20(1):87-96. PubMed ID: 15479859 [TBL] [Abstract][Full Text] [Related]
15. Genetic variants of chemokine receptor CCR7 in patients with systemic lupus erythematosus, Sjogren's syndrome and systemic sclerosis. Kahlmann D; Davalos-Misslitz AC; Ohl L; Stanke F; Witte T; Förster R BMC Genet; 2007 Jun; 8():33. PubMed ID: 17587445 [TBL] [Abstract][Full Text] [Related]
16. Novel single nucleotide polymorphisms in the specific protein 1 binding site of the bovine PRNP promoter in Japanese Black cattle: impairment of its promoter activity. Nakamura I; Xue G; Sakudo A; Saeki K; Matsumoto Y; Ikuta K; Onodera T Intervirology; 2007; 50(3):190-6. PubMed ID: 17283444 [TBL] [Abstract][Full Text] [Related]
17. Identification of a novel 12-nucleotide insertion polymorphism in the promoter region of ADRA2B: full linkage with the 9-nucleotide deletion in the coding region and influence on transcriptional activity. Crassous PA; Blaise R; Marquette A; Snapir A; Scheinin M; Paris H; Schaak S Biochem Pharmacol; 2010 Feb; 79(3):407-12. PubMed ID: 19728989 [TBL] [Abstract][Full Text] [Related]
18. No direct effect of the -521 C/T polymorphism in the human dopamine D4 receptor gene promoter on transcriptional activity. Kereszturi E; Kiraly O; Barta C; Molnar N; Sasvari-Szekely M; Csapo Z BMC Mol Biol; 2006 May; 7():18. PubMed ID: 16723017 [TBL] [Abstract][Full Text] [Related]
19. Single nucleotide polymorphisms of the human cyp2a13 gene: evidence for a null allele. Zhang X; Chen Y; Liu Y; Ren X; Zhang QY; Caggana M; Ding X Drug Metab Dispos; 2003 Sep; 31(9):1081-5. PubMed ID: 12920161 [TBL] [Abstract][Full Text] [Related]
20. Characterization of the in vitro transcriptional activity of polymorphic alleles of the human monoamine oxidase-B gene. Costa-Mallen P; Kelada SN; Costa LG; Checkoway H Neurosci Lett; 2005 Jul 22-29; 383(1-2):171-5. PubMed ID: 15936531 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]